170 related articles for article (PubMed ID: 30859110)
1. MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against
Broset E; Saubi N; Guitart N; Aguilo N; Uranga S; Kilpeläinen A; Eto Y; Hanke T; Gonzalo-Asensio J; Martín C; Joseph-Munné J
Mol Ther Methods Clin Dev; 2019 Jun; 13():253-264. PubMed ID: 30859110
[TBL] [Abstract][Full Text] [Related]
2. Preclinical development of BCG.HIVA
Mahant A; Saubi N; Eto Y; Guitart N; Gatell JM; Hanke T; Joseph J
Hum Vaccin Immunother; 2017 Aug; 13(8):1798-1810. PubMed ID: 28426273
[TBL] [Abstract][Full Text] [Related]
3. Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG.
Saubi N; Gea-Mallorquí E; Ferrer P; Hurtado C; Sánchez-Úbeda S; Eto Y; Gatell JM; Hanke T; Joseph J
Mol Ther Methods Clin Dev; 2014; 1():14017. PubMed ID: 26015961
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG.
Saubi N; Mbewe-Mvula A; Gea-Mallorqui E; Rosario M; Gatell JM; Hanke T; Joseph J
PLoS One; 2012; 7(8):e42559. PubMed ID: 22927933
[TBL] [Abstract][Full Text] [Related]
5. Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
Hopkins R; Bridgeman A; Joseph J; Gilbert SC; McShane H; Hanke T
PLoS One; 2011; 6(5):e20067. PubMed ID: 21603645
[TBL] [Abstract][Full Text] [Related]
6. Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques.
Rosario M; Hopkins R; Fulkerson J; Borthwick N; Quigley MF; Joseph J; Douek DC; Greenaway HY; Venturi V; Gostick E; Price DA; Both GW; Sadoff JC; Hanke T
J Virol; 2010 Jun; 84(12):5898-908. PubMed ID: 20375158
[TBL] [Abstract][Full Text] [Related]
7. Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.
Kilpeläinen A; Saubi N; Guitart N; Moyo N; Wee EG; Ravi K; Hanke T; Joseph J
Front Immunol; 2019; 10():923. PubMed ID: 31156614
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
Rosario M; Fulkerson J; Soneji S; Parker J; Im EJ; Borthwick N; Bridgeman A; Bourne C; Joseph J; Sadoff JC; Hanke T
J Virol; 2010 Aug; 84(15):7815-21. PubMed ID: 20484495
[TBL] [Abstract][Full Text] [Related]
9. Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.
Kilpeläinen A; Saubi N; Guitart N; Olvera A; Hanke T; Brander C; Joseph J
Vaccines (Basel); 2019 Aug; 7(3):. PubMed ID: 31382453
[TBL] [Abstract][Full Text] [Related]
10. Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.
Solans L; Uranga S; Aguilo N; Arnal C; Gomez AB; Monzon M; Badiola JJ; Gicquel B; Martin C
Vaccine; 2014 Sep; 32(40):5192-7. PubMed ID: 25066740
[TBL] [Abstract][Full Text] [Related]
11. Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
Hopkins R; Bridgeman A; Bourne C; Mbewe-Mvula A; Sadoff JC; Both GW; Joseph J; Fulkerson J; Hanke T
Eur J Immunol; 2011 Dec; 41(12):3542-52. PubMed ID: 21932450
[TBL] [Abstract][Full Text] [Related]
12. Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential.
Pérez I; Uranga S; Sayes F; Frigui W; Samper S; Arbués A; Aguiló N; Brosch R; Martín C; Gonzalo-Asensio J
EBioMedicine; 2020 May; 55():102761. PubMed ID: 32361249
[TBL] [Abstract][Full Text] [Related]
13. MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic.
Gonzalo-Asensio J; Marinova D; Martin C; Aguilo N
Front Immunol; 2017; 8():1803. PubMed ID: 29326700
[TBL] [Abstract][Full Text] [Related]
14. Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.
Spertini F; Audran R; Chakour R; Karoui O; Steiner-Monard V; Thierry AC; Mayor CE; Rettby N; Jaton K; Vallotton L; Lazor-Blanchet C; Doce J; Puentes E; Marinova D; Aguilo N; Martin C
Lancet Respir Med; 2015 Dec; 3(12):953-62. PubMed ID: 26598141
[TBL] [Abstract][Full Text] [Related]
15. MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice.
Aguilo N; Uranga S; Marinova D; Monzon M; Badiola J; Martin C
Tuberculosis (Edinb); 2016 Jan; 96():71-4. PubMed ID: 26786657
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
Singh S; Saraav I; Sharma S
Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
[TBL] [Abstract][Full Text] [Related]
19. Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice.
Saubi N; Kilpeläinen A; Eto Y; Chen CW; Olvera À; Hanke T; Brander C; Joseph-Munné J
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33202884
[TBL] [Abstract][Full Text] [Related]
20. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
